S&P 500 7,500.58 ▲ 80.48 (+1.08%) DOW 51,564.70 ▲ 72.15 (+0.14%) NASDAQ 26,517.93 ▲ 496.28 (+1.91%) US Markets Closed â€ĸ 02:17 AM ET

BYAH

Park Ha Biological Technology Co., Ltd.

Price Chart
Latest Quote

$1.32

+0.12 (+10.00%)
Current Price
Previous Close $1.20
Open $1.67
Day High $1.68
Day Low $1.32
Volume 10,990,559
Fetched: 2026-06-19T06:17:58
Stock Information
Shares Outstanding 3.97M
Total Debt $180K
Cash Equivalents $3.79M
Revenue $2.52M
Net Income $-24.36M
Sector Consumer Defensive
Industry Household & Personal Products
Market Cap $5.75M
EPS (TTM) $-2069.00
Exchange NCM
🌐 Visit Website
📊 Comprehensive Analysis
Company Data
Enterprise Value$-2.59M
Sales$2.52M
Income$-24.36M
Book/sh$5.90
Cash/sh$0.95
Employees41
Financial Ratios
Quick Ratio2.15
Current Ratio2.92
Debt/Eq4.51
Returns & Margins
ROA-334.07%
ROE-885.84%
Gross Margin94.36%
Operating Margin-344.83%
Ownership
Insider Ownership32.96%
Institutional Ownership0.00%
Insider & Institutional transactions data not available
Valuation Ratios
P/S2.28
P/B0.22
Analyst Data
Recommendationnone
Technical Indicators
SMA20$1.32
SMA50$1.22
SMA200$8.76
RSI51.11
ATR0.8927
Shares Float100K
Short Float0.61%
Short Ratio0.58
Rel Volume1.19
Performance History
Week+25.71%
Month+21.10%
Quarter+24.53%
6 Months-86.80%
YTD-84.47%
Year-99.88%
10 Years-99.35%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-06-18 $1.32 11,149,300
2026-06-17 $1.20 6,810,300
2026-06-16 $1.50 1,486,800
2026-06-15 $1.48 12,491,200
2026-06-12 $1.47 104,713,500
2026-06-11 $1.05 27,504,300
2026-06-10 $1.24 412,000
2026-06-09 $1.56 2,247,300
2026-06-08 $2.65 21,198,800
2026-06-05 $1.06 8,100
2026-06-04 $1.29 19,500
2026-06-03 $1.23 2,800
2026-06-02 $1.25 36,900
2026-06-01 $1.17 5,900
2026-05-29 $1.22 10,400
2026-05-28 $1.20 8,000
2026-05-27 $1.22 28,200
2026-05-26 $1.09 4,400
2026-05-22 $1.08 11,600
2026-05-21 $1.12 4,200
2026-05-20 $1.08 10,900
2026-05-19 $1.09 22,600
About Park Ha Biological Technology Co., Ltd.

Park Ha Biological Technology Co., Ltd., investment holding company, develops skincare products in the People's Republic of China. It operates in two segments, Product Sales and Franchise Service. The company offers various products, such as basic skin physical protection, exfoliation, and sebum film repair to surface microecological balance, and anti-aging under the Park Ha brand. It sells products to customers through directly operated retail stores, and franchisees. The company has a strategic partnership with Star Plus Action (HK) Limited to build an AI-powered skincare and health ecosystem and expand its healthcare reach. The company was founded in 2016 and is headquartered in Wuxi, the People's Republic of China. Park Ha Biological Technology Co., Ltd. operates as a subsidiary of Xiaoqiu Holding Ltd.

Period:
Loading...
Income Statement (Annual)
Metric 2025-10-31 2024-10-31 2023-10-31 2022-10-31
Revenue
Reconciled Cost Of Revenue $142,526 $195,336 $310,989 $509,162
Cost Of Revenue $142,526 $195,336 $310,989 $509,162
Total Revenue $2,524,843 $2,381,851 $2,459,102 $1,919,389
Operating Revenue $2,524,843 $2,381,851 $2,459,102 $1,919,389
Expenses
Interest Expense $41 $0 $0 $194
Total Expenses $26,673,744 $1,588,137 $1,278,548 $1,722,365
Other Income Expense $58,738 $-1,076 $-575 $-7,083
Other Non Operating Income Expenses $58,738 $-1,076 $-575 $-7,083
Net Non Operating Interest Income Expense $6,056 $783 $1,590 $69
Interest Expense Non Operating $41 $0 $0 $194
Operating Expense $26,531,218 $1,392,801 $967,559 $1,213,203
Selling And Marketing Expense $625,289 $361,327 $299,615 $438,603
General And Administrative Expense $25,483,541 $814,857 $484,955 $707,487
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-24,364,753 $478,561 $852,042 $191,298
Net Interest Income $6,056 $783 $1,590 $69
Interest Income $6,097 $783 $1,590 $263
Normalized Income $-24,364,753 $478,561 $852,042 $191,298
Net Income From Continuing And Discontinued Operation $-24,364,753 $478,561 $852,042 $191,298
Total Operating Income As Reported $-24,148,901 $793,714 $1,180,554 $197,024
Net Income Common Stockholders $-24,364,753 $478,561 $852,042 $191,298
Net Income $-24,364,753 $478,561 $852,042 $191,298
Net Income Including Noncontrolling Interests $-24,364,753 $478,561 $852,042 $191,298
Net Income Continuous Operations $-24,364,753 $478,561 $852,042 $191,298
Pretax Income $-24,084,107 $793,421 $1,181,569 $190,010
Interest Income Non Operating $6,097 $783 $1,590 $263
Operating Income $-24,148,901 $793,714 $1,180,554 $197,024
Gross Profit $2,382,317 $2,186,515 $2,148,113 $1,410,227
Per Share
Diluted EPS - $0.91 $1.63 $0.37
Basic EPS - $0.91 $1.63 $0.37
Other
Tax Effect Of Unusual Items $0 $0 $0 $0
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $-23,974,697 $816,107 $1,201,632 $220,695
Reconciled Depreciation $109,369 $22,686 $20,063 $30,491
EBITDA (Bullshit earnings) $-23,974,697 $816,107 $1,201,632 $220,695
EBIT $-24,084,066 $793,421 $1,181,569 $190,204
Diluted NI Availto Com Stockholders $-24,364,753 $478,561 $852,042 $191,298
Tax Provision $280,646 $314,860 $329,527 $-1,288
Provision For Doubtful Accounts $184,204 $179,903 $152,108 $6,442
Research And Development $238,184 $36,714 $30,881 $60,671
Selling General And Administration $26,108,830 $1,176,184 $784,570 $1,146,090
Other Gand A $25,483,541 $814,857 $484,955 $707,487
Diluted Average Shares - $524,000 $524,000 $524,000
Basic Average Shares - $524,000 $524,000 $524,000
Fetched: 2026-06-18
Balance Sheet (Annual)
Metric 2025-10-31 2024-10-31 2023-10-31 2022-10-31
Assets
Net Tangible Assets $3,988,216 $1,498,464 $1,004,069 $140,928
Total Assets $5,952,616 $3,083,283 $2,264,867 $2,518,722
Total Non Current Assets $450,654 $239,037 $88,721 $254,091
Non Current Prepaid Assets $22,416 $407 $9,882 $3,849
Non Current Deferred Assets $83,357 $56,310 $0 -
Non Current Deferred Taxes Assets $83,357 $56,310 $0 -
Goodwill And Other Intangible Assets $6,639 $7,621 $8,404 $9,349
Other Intangible Assets $6,639 $7,621 $8,404 $9,349
Current Assets $5,501,962 $2,844,246 $2,176,146 $2,264,631
Current Deferred Assets $0 $1,088,400 $233,476 $59,520
Prepaid Assets $347,247 $27,198 $102,388 $10,574
Inventory $75,214 $71,486 $95,870 $94,170
Receivables $1,291,823 $1,109,664 $710,778 $1,525,656
Receivables Adjustments Allowances $-11,002 $-51,013 - -
Other Receivables $25,765 $69,454 $31,487 $15,837
Loans Receivable $1,021,181 $745,992 $300,315 $1,377,676
Accounts Receivable $255,844 $330,892 $361,735 $119,212
Allowance For Doubtful Accounts Receivable $-144,859 $-231,851 $-90,504 $-5,833
Gross Accounts Receivable $400,703 $562,743 $452,239 $125,045
Cash Cash Equivalents And Short Term Investments $3,787,678 $547,498 $1,033,634 $574,711
Cash And Cash Equivalents $3,787,678 $547,498 $1,033,634 $574,711
Cash Financial $3,787,678 $547,498 $1,033,634 $574,711
Current Deferred Taxes Assets - $0 $33,830 $1,167
Non Current Accounts Receivable - - - $178,074
Debt
Total Debt $180,169 $70,318 $31,462 $26,194
Long Term Debt And Capital Lease Obligation $75,915 $52,745 $9,492 $0
Current Debt And Capital Lease Obligation $104,254 $17,573 $21,970 $26,194
Liabilities
Total Liabilities Net Minority Interest $1,957,761 $1,577,198 $1,252,394 $2,368,445
Total Non Current Liabilities Net Minority Interest $75,915 $52,745 $9,492 $0
Current Liabilities $1,881,846 $1,524,453 $1,242,902 $2,368,445
Current Deferred Liabilities $194,753 $325,924 $250,549 $1,206,109
Payables And Accrued Expenses $1,582,839 $1,180,956 $970,383 $1,136,142
Payables $1,394,527 $1,025,093 $845,227 $1,045,295
Total Tax Payable $1,375,488 $1,001,024 $579,911 $156,271
Income Tax Payable $1,010,451 $699,633 $351,691 $0
Accounts Payable $12,013 $24,069 $197,155 $129,723
Equity
Common Stock Equity $3,994,855 $1,506,085 $1,012,473 $150,277
Total Equity Gross Minority Interest $3,994,855 $1,506,085 $1,012,473 $150,277
Stockholders Equity $3,994,855 $1,506,085 $1,012,473 $150,277
Gains Losses Not Affecting Retained Earnings $150,864 $72,586 $-43,505 $-45,816
Other Equity Adjustments $150,864 $72,586 $-43,505 $-45,816
Retained Earnings $-24,178,267 $271,788 $-105,233 $-926,853
Other Equity Interest - - $-500 $-500
Other
Ordinary Shares Number $677,488 $524,000 $524,000 $524,000
Share Issued $677,488 $524,000 $524,000 $524,000
Tangible Book Value $3,988,216 $1,498,464 $1,004,069 $140,928
Invested Capital $3,994,855 $1,506,085 $1,012,473 $150,277
Working Capital $3,620,116 $1,319,793 $933,244 $-103,814
Capital Lease Obligations $180,169 $70,318 $31,462 $26,194
Total Capitalization $3,994,855 $1,506,085 $1,012,473 $150,277
Additional Paid In Capital $28,021,581 $1,161,211 $1,161,211 $1,122,946
Capital Stock $677 $500 $500 $500
Common Stock $677 $500 $500 $500
Long Term Capital Lease Obligation $75,915 $52,745 $9,492 $0
Current Deferred Revenue $194,753 $325,924 $250,549 $1,206,109
Current Capital Lease Obligation $104,254 $17,573 $21,970 $26,194
Current Accrued Expenses $188,312 $155,863 $125,156 $90,847
Dueto Related Parties Current $7,026 $0 $68,161 $759,301
Net PPE $338,242 $174,699 $70,435 $62,819
Accumulated Depreciation $-277,290 $-167,372 $-142,053 $-123,383
Gross PPE $615,532 $342,071 $212,488 $186,202
Leases $265,653 $106,775 $21,953 $0
Other Properties $180,243 $70,739 $31,864 $27,795
Machinery Furniture Equipment $169,636 $164,557 $158,671 $158,407
Properties $0 $0 $0 $0
Inventories Adjustments Allowances $-12,531 $0 - -
Finished Goods $74,491 $48,880 $59,130 $53,995
Raw Materials $13,254 $22,606 $36,740 $40,175
Duefrom Related Parties Current $35 $14,339 $17,241 $12,931
Fetched: 2026-06-18
Cash Flow Statement (Annual)
Metric 2025-10-31 2024-10-31 2023-10-31 2022-10-31
Free Cash Flow
Free Cash Flow $-2,973 $874,901 $103,861 $1,430,416
Operating Activities
Operating Cash Flow $85,852 $960,470 $126,537 $1,442,306
Cash Flow From Continuing Operating Activities $85,852 $960,470 $126,537 $1,442,306
Investing Activities
Capital Expenditure $-88,825 $-85,569 $-22,676 $-11,890
Investing Cash Flow $-572,927 $-508,143 $1,023,419 $-1,547,610
Cash Flow From Continuing Investing Activities $-572,927 $-508,143 $1,023,419 $-1,547,610
Net Other Investing Changes $-484,102 $-422,574 $1,046,095 $-1,535,720
Financing Activities
Issuance Of Capital Stock $4,277,807 $500 $38,265 $534,149
Financing Cash Flow $3,735,677 $-957,389 $-676,925 $669,652
Cash Flow From Continuing Financing Activities $3,735,677 $-957,389 $-676,925 $669,652
Net Other Financing Charges $-549,060 $-888,754 - -
Net Common Stock Issuance $4,277,807 $500 $38,265 $534,149
Common Stock Issuance $4,277,807 $500 $38,265 $534,149
Other
Repayment Of Debt $0 $-73,310 $-776,083 $-257,557
Issuance Of Debt $6,930 $4,175 $60,893 $393,060
Interest Paid Supplemental Data $0 $0 $0 $194
End Cash Position $3,787,678 $547,498 $1,033,634 $574,711
Beginning Cash Position $547,498 $1,033,634 $574,711 $72,686
Effect Of Exchange Rate Changes $-8,422 $18,926 $-14,108 $-62,323
Changes In Cash $3,248,602 $-505,062 $473,031 $564,348
Net Issuance Payments Of Debt $6,930 $-69,135 $-715,190 $135,503
Net Long Term Debt Issuance $6,930 $-69,135 $-715,190 $135,503
Long Term Debt Payments $0 $-73,310 $-776,083 $-257,557
Long Term Debt Issuance $6,930 $4,175 $60,893 $393,060
Net PPE Purchase And Sale $-88,825 $-85,569 $-22,676 $-11,890
Purchase Of PPE $-88,825 $-85,569 $-22,676 $-11,890
Change In Working Capital $-91,475 $254,405 $-911,066 $1,173,763
Change In Other Working Capital $-129,424 $68,725 $-989,082 $1,172,485
Change In Other Current Liabilities $-37,043 $-30,435 $-44,654 $-33,032
Change In Other Current Assets $-20,323 $9,620 $178,016 $-187,491
Change In Payables And Accrued Expense $355,495 $254,716 $542,018 $178,257
Change In Accrued Expense $-1,843 $27,450 $35,281 $39,370
Change In Payable $357,338 $227,266 $506,737 $138,887
Change In Account Payable $-11,894 $-176,130 $69,427 $56,808
Change In Tax Payable $369,232 $403,396 $437,310 $82,079
Change In Income Tax Payable $369,232 $403,396 $437,310 $82,079
Change In Prepaid Assets $9,618 $76,909 $8,959 $-6,190
Change In Inventory $-17,458 $10,472 $-2,823 $193,581
Change In Receivables $-252,340 $-135,602 $-603,500 $-143,847
Changes In Account Receivables $71,978 $-98,740 $-337,745 $-87,783
Other Non Cash Items $191,188 $30,425 $45,896 $32,902
Stock Based Compensation $24,070,200 $0 $0 -
Provisionand Write Offof Assets $196,564 $179,903 $152,108 $6,442
Asset Impairment Charge $1,430 $15,955 $1,231 $8,698
Deferred Tax $-26,671 $-21,465 $-33,737 $-1,288
Deferred Income Tax $-26,671 $-21,465 $-33,737 $-1,288
Depreciation Amortization Depletion $109,369 $22,686 $20,063 $30,491
Depreciation And Amortization $109,369 $22,686 $20,063 $30,491
Amortization Cash Flow $970 $974 - -
Amortization Of Intangibles $970 $974 - -
Depreciation $108,399 $21,712 - -
Net Income From Continuing Operations $-24,364,753 $478,561 $852,042 $191,298
Income Tax Paid Supplemental Data - - - $0
Fetched: 2026-06-18